Varuma AG

Varuma AG

This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Headquarters Location

Switzerland, Basel


The VC's location is in Europe, Switzerland. The main office of this Corporate Investor is situated in Basel.

Among the most popular portfolio start-ups of the fund, are Addex Therapeutics, Santhera Pharmaceuticals. Among the most popular investment industries for the fund are Pharmaceutical, Biotechnology. However, the fund’s focus is not limited to this, since there are 2 more areas of investment. The country of its establishment and the country of its most frequent investments coincides - Switzerland. Also, a start-up has to be aged 2-3 years to expect investment from this fund.

The fund typically enters into less than 2 deals annually. We recorded the biggest number of exits for this fund in 2007. Varuma AG participates, on average, in 38 percentage points more than the average amount of lead investments in other funds. In 2006, the fund's activity was at its peak. The most common rounds for this fund are in the range of 10 - 50 millions dollars.

The fund typically invests in rounds with 7-8 participants. Besides Varuma AG, start-ups are typically funded by Techno Venture Management, Sofinnova Partners, Novartis Venture Fund and 2 more VCs. The most common co-investors for the fund are Novartis Venture Fund, The Dow Chemical Company, Sofinnova Partners. In subsequent rounds, the fund is usually supported by Biotechnology Value Fund, YA Global Master SPV, The Dow Chemical Company.

Fund Activity

Not operative

Mail Rule [rules by which you can get an email of an interesting for you fund employee, knowing only the name and surname of this employee]

Domain name:; User name format in descending order of probability: first '.' last, first

Group Appearance [how often fund is operating separately from groups with shared interest]

100.0% of cases

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: